Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men

Jean-Yves Reginster; Eric Abadie; Gonzalo Calvo; Olof Johnell; Jean-Marc Kaufman; Gottfried Kreutz; Andrea Laslop; Fritz Lekkerkerker; Bruce Mitlak; Per Nilsson; John Orloff; Mary Smillie; Pierre Delmas; Andrew Taylor; Yannis Tsouderos; Dominique Ethgen; Bruno Flamion; Rene Rizzoli; Willard Dere; Philippevan DER AUWERA; Bernard Avouac; Maria-Luisa Brandi; Anastasia Daifotis; Adolfo DIEZ-PEREZ

doi:10.1007/s00198-005-1984-3

Back

Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men

Journal article

Peer reviewed

Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men

Jean-Yves Reginster, Eric Abadie, Gonzalo Calvo, Olof Johnell, Jean-Marc Kaufman, Gottfried Kreutz, Andrea Laslop, Fritz Lekkerkerker, Bruce Mitlak, Per Nilsson, …

Osteoporosis international, Vol.17(1), pp.1-7

2006

DOI: https://doi.org/10.1007/s00198-005-1984-3

PMID: 16091835

Abstract

Biological and medical sciences

Diseases of the osteoarticular system

Drug addictions

Medical sciences

Osteoporosis. Osteomalacia. Paget disease

Toxicology

Metrics

1 Record Views

Details

Title: Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men
Creators - without role: Jean-Yves Reginster - University of Liège
Eric Abadie - University of Liège
Gonzalo Calvo - Hospital de Sant Pau
Olof Johnell - Malmö University
Jean-Marc Kaufman - Department of Endocrinology, University Hospital Gent, Gent, Belgium
Gottfried Kreutz - American Rock Mechanics Association
Andrea Laslop - Universität Innsbruck
Fritz Lekkerkerker - Medicines Evaluation Board
Bruce Mitlak - Eli Lilly
Per Nilsson - Medical Product Agency, Uppsala, Sweden
John Orloff - Novartis
Mary Smillie - TEVA, United Kingdom
Pierre Delmas - Clinique Claude-Bernard
Andrew Taylor - Pfizer
Yannis Tsouderos - Servier
Dominique Ethgen - GlaxoSmithKline
Bruno Flamion - Notre Dame of Dadiangas University
Rene Rizzoli - University Hospital of Geneva
Willard Dere - Electronic Sensor Technology
Philippevan DER AUWERA - F. Hoffmann-La Roche Ltd, Basle, Switzerland
Bernard Avouac - Hôpitaux Universitaires Henri-Mondor
Maria-Luisa Brandi - Florence
Anastasia Daifotis - Merck, Whitehouse Station, NJ, United States
Adolfo DIEZ-PEREZ - Hospital Del Mar
Publication Details: Osteoporosis international, Vol.17(1), pp.1-7
Publisher: Springer
Identifiers: 9947550208331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article